Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 22025-12-30NCT04604067

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Swiss Cancer Institute29

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Azienda Ospedaliera Universitaria Maggiore della Carita di NovaraNovaraItaly1
Centre hospitalier universitaire vaudoisLausanneSwitzerland3
City Hospital TriemliZurichSwitzerland1
Hopital FribourgeoisFribourgSwitzerland2
Hopitaux Universitaire de Genève (HUG)GenevaSwitzerland1
Inselspital, BernBernSwitzerland2
Istituto Oncologico della Svizzera ItalianaBellinzonaSwitzerland6
Kantonsspital AarauAarauSwitzerland7
Kantonsspital Baden (Baden/Brugg)BadenSwitzerland1
Kantonsspital GraubündenChurSwitzerland22
Kantonsspital LuzernLuzerneSwitzerland1
Kantonsspital OltenOltenSwitzerland2
Kantonsspital St. GallenSankt GallenSwitzerland27
Kantonsspital WinterthurWinterthurSwitzerland27
Ospedale Papa Giovanni XXIIIBergamoItaly1
Policlinico Agostino GemelliRomaItaly3
Réseau Hospitalier Neuchâtelois (RHNe)NeuchâtelSwitzerland1
St. ClaraspitalBaselSwitzerland5
Universitätsspital ZürichZurichSwitzerland43